Albiflorin
Based on 7 publication(s) in Google Scholar
Albiflorin, a major constituent contained in peony root, is a brain-penetrant monoterpene glycoside with neuroprotective effects. Albiflorin also has anti-inflammatory, antioxidant and antinociceptive effects.
For research use only. We do not sell to patients.
- Purity: 98.67%
- CAS No.: 39011-90-0
- Formula: C23H28O11
- Molecular Weight:480.46
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Albiflorin
More- Antioxidants. 2025 Jun 27;14(7):795. [Abstract]
- Drug Des Devel Ther. 2024 Jun 20:18:2405-2420. [Abstract]
- Int Immunopharmacol. 2024 Sep 27;142(Pt B):113245. [Abstract]
- J Pharm Pharmacol. 2023 Oct 5;75(10):1332-1343. [Abstract]
- Immunopharmacol Immunotoxicol. 2025 Feb 9:1-12. [Abstract]
- Immun Inflamm Dis. 2023 Sep;11(9):e1015. [Abstract]
- SSRN. 2025 Aug 13.
-
Cell Proliferation/Viability Assay
-
IF
-
WB
-
RT-PCR
-
Histological Imaging/Staining
Biological Activity
Albiflorin (50-200 μM; pretreated for 3 hours; PC12 cells) treatment significantly ameliorates glutamate (Glu)-induced reduction of cell viability[1].
Albiflorin (100 μM; pretreated for 3 hours; PC12 cells) treatment significantly ameliorates Glu-induced reduction of nuclear and mitochondrial apoptotic alteration, reactive oxygen species accumulation, and B-cell lymphoma 2 (Bcl-2)/Bax ratio[1].
Albiflorin (100 μM; pretreated for 3 hours; PC12 cells) treatment enhances phosphorylation of AKT and its downstream element GSK-3β[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PC12 cells
-
Concentration:50 μM, 100 μM, 200 μM
-
Incubation Time:Pretreated for 3 hours
-
Result:Significantly ameliorated Glu-induced reduction of cell viability.
-
Cell Line:PC12 cells
-
Concentration:100 μM
-
Incubation Time:Pretreated for 3 hours
-
Result:Significantly ameliorated Glu-induced reduction of nuclear and mitochondrial apoptotic alteration.
-
Cell Line:PC12 cells
-
Concentration:100 μM
-
Incubation Time:Pretreated for 3 hours
-
Result:Enhanced phosphorylation of AKT and its downstream element GSK-3β.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar rats (7-week-old; 200-220 g) bearing chronic constriction injury (CCI)[2]
-
Dosage:50 mg/kg
-
Administration:Intraperitoneal injection; once a day; for 15 days
-
Result:Significantly increased the paw withdrawal threshold (PWT) on the 11th and 15th day after surgery.
Chemical Information
-
CAS No. 39011-90-0
-
Appearance Solid
-
Molecular Weight 480.46
-
Formula C23H28O11
-
Color White to off-white
-
SMILES
O=C(C1=CC=CC=C1)OC[C@@]2([C@@]([C@H](O)C[C@@]3(OC2=O)C)([H])C4)[C@]43O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)CO
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (7)
-
Journal Impact Factor
-
Most Recent
-
Antioxidants
Integration of Transcriptomic Analysis, Network Pharmacology, and Experimental Validation Demonstrates Enhanced Muscle-Protective Effects of Ethanol Extract of Jakyak-Gamcho-Tang. [Abstract]2025 Jun 27;14(7):795. PMID: 40722900 -
Drug Des Devel Ther
Exploration of the Active Component and Mechanisms of Shengyu Decoction Against Myelosuppression Using Network Pharmacology and in vitro Experimental Validation. [Abstract]2024 Jun 20:18:2405-2420. PMID: 38915868 -
Int Immunopharmacol
Albiflorin inhibits osteoclastogenesis and titanium particles-induced osteolysis via inhibition of ROS accumulation and the PI3K/AKT signaling pathway. [Abstract]2024 Sep 27;142(Pt B):113245. PMID: 39340985
Albiflorin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Sep 27;142(Pt B):113245. [Abstract]
CCK8 assay of Albiflorin (AF) (0, 1, 2, 5, 10, 20, 50, 100, 200, 500 μM) on RAW264.7 cells viability for 24, 72 h.
Albiflorin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Sep 27;142(Pt B):113245. [Abstract]
Representative images of F-actin staining showing RAW264.7 cells treated with Albiflorin (AF) (20, 50 μM).
Albiflorin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Sep 27;142(Pt B):113245. [Abstract]
The Western Blot showing the levels of osteoclastogenesis related proteins treated with Albiflorin (AF) (20, 50 μM).
Albiflorin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Sep 27;142(Pt B):113245. [Abstract]
RT-PCR results showing expression levels of CTSK, NFATc1, Acp5, and DCSATMP mRNA treated with Albiflorin (AF) (20, 50 μM).
Albiflorin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2024 Sep 27;142(Pt B):113245. [Abstract]
H&E staining of cranial tissues of mice treated with Albiflorin (AF) (10 mg/kg, i.p.).
-
J Pharm Pharmacol
Albiflorin alleviation efficacy in osteoarthritis injury using in-vivo and in-vitro models. [Abstract]2023 Oct 5;75(10):1332-1343. PMID: 37403239 -
Immunopharmacol Immunotoxicol
Albiflorin ameliorates neuroinflammation and exerts neuroprotective effects in Parkinson's disease models. [Abstract]2025 Feb 9:1-12. PMID: 39924948 -
Immun Inflamm Dis
Effects of albiflorin on oxidative stress and inflammatory responses in rats with acute spinal cord injury. [Abstract]2023 Sep;11(9):e1015. PMID: 37773716 -
Solvent & Solubility
DMSO : ≥ 100 mg/mL (208.13 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : 100 mg/mL (208.13 mM; Need ultrasonic)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.20 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (5.20 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 100 mg/mL (208.13 mM); Clear solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
Purity & Documentation
-
Data Sheet (289 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Portuguese - PT (254 KB)
-
Handling Instructions (2659 KB)
References
[1]. Wang D, et al. Neuroprotective effects of paeoniflorin, but not the isomer albiflorin, are associated with the suppression of intracellular calcium and calcium/calmodulin protein kinase II in PC12 cells. J Mol Neurosci. 2013 Oct;51(2):581-90. [Content Brief]
[2]. Jianyu Zhou, et al. Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats. Evid Based Complement Alternat Med. 2016;2016:8082753. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO / H2O | 1 mM | 2.0813 mL | 10.4067 mL | 20.8134 mL | 52.0335 mL |
| 5 mM | 0.4163 mL | 2.0813 mL | 4.1627 mL | 10.4067 mL | |
| 10 mM | 0.2081 mL | 1.0407 mL | 2.0813 mL | 5.2033 mL | |
| 15 mM | 0.1388 mL | 0.6938 mL | 1.3876 mL | 3.4689 mL | |
| 20 mM | 0.1041 mL | 0.5203 mL | 1.0407 mL | 2.6017 mL | |
| 25 mM | 0.0833 mL | 0.4163 mL | 0.8325 mL | 2.0813 mL | |
| 30 mM | 0.0694 mL | 0.3469 mL | 0.6938 mL | 1.7344 mL | |
| 40 mM | 0.0520 mL | 0.2602 mL | 0.5203 mL | 1.3008 mL | |
| 50 mM | 0.0416 mL | 0.2081 mL | 0.4163 mL | 1.0407 mL | |
| 60 mM | 0.0347 mL | 0.1734 mL | 0.3469 mL | 0.8672 mL | |
| 80 mM | 0.0260 mL | 0.1301 mL | 0.2602 mL | 0.6504 mL | |
| 100 mM | 0.0208 mL | 0.1041 mL | 0.2081 mL | 0.5203 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.